During the past decade, Comprehensive Center for Bleeding Disorders conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Center for Bleeding Disorders" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Manchester University NHS Foundation Trust" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Center for Bleeding Disorders" are "Von Willebrand Disease" (2 trials), "Haemophilia A Without Inhibitor" (1 trials), "Haemophilia B Without Inhibitor" (1 trials), "Hemophilia A" (1 trials) and "Hemophilia A With Inhibitor" (1 trials). Many other conditions were trialed in "Comprehensive Center for Bleeding Disorders" in a lesser frequency.

Most popular intervention types in "Comprehensive Center for Bleeding Disorders" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antihemophilic Factor (Recombinant)" (1 trials), "Factor VIII concentrates" (1 trials), "High-dose treatment" (1 trials), "Low-dose treatment" (1 trials) and "Marketed plasma-derived VWF/FVIII concentrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Center for Bleeding Disorders" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Center for Bleeding Disorders". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Comprehensive Center for Bleeding Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Center for Bleeding Disorders, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".